Predict your next investment

Corporation
HEALTHCARE | Medical Devices & Equipment
courtagen.com

See what CB Insights has to offer

Stage

Series C | Dead

Total Raised

$35.12M

Last Raised

$20M

About Courtagen Life Sciences

Courtagen Life Sciences (CLS) provides proteomic and genomic products and services to the Life Sciences industry. The company delivers tools that enable researchers and clinicians to make better decisions regarding drug development and patient care. Avantra Biosciences, a subsidiary of Courtagen Life Sciences, sells instruments, consumables and services to address the need for simple multiplex immunoassays in the research, pre-clinical and clinical diagnostic segments of the Life Sciences industry.

Courtagen Life Sciences Headquarter Location

8 Cabot Road Suite 2000

Woburn, Massachusetts, 01801,

United States

866-574-3582

Latest Courtagen Life Sciences News

Expanded Speaker List for Medical Cannabis Health and Research Conference

Sep 11, 2019

February 10, 2017 -- WOBURN, Mass.--(BUSINESS WIRE)--Medicinal Genomics and Courtagen Life Sciences, today announced an increasingly influential speaker lineup for CannMed 2017. This second annual Personalized Cannabinoid Medicine Conference will be held at The Joseph B. Martin Conference Center at The Harvard School of Medicine April 9-11, 2017. The conference will feature internationally recognized thought leaders, scientists, physicians, and advocates working to advance research into the endocannabinoid system and cannabinoid therapeutics. "We are excited to have the top thought-leaders in medicine, research, and industry on board for our second annual conference to discuss the most important issues impacting the cannabis industry today," said Kevin McKernan, Chief Science Officer, Courtagen. "The conference will showcase the important work of these individuals and cover a range of topics including medical applications for cancer, neurology, and other conditions, mobile applications, and critical topical issues such as opioid dependence and medical cannabis safety related to bacterial and fungal contamination." In addition to Dr. Raphael Mechoulam, cannabis research pioneer and the "Father of Marijuana Research," speakers will include: Michael Dor, MD – Chief Medical Officer of the Israeli Ministry of Foreign Affairs and the Chief Medical Consultant in the Israeli Health Ministry’s Medical Cannabis Unit. Bonni Goldstein, MD – Medical Director of Canna-Centers, a California medical practice devoted to educating patients about the use of cannabis for serious and chronic medical conditions. Elizabeth Anne Thiele, PhD, MD – Director, Pediatric Epilepsy Program at Massachusetts General Hospital. Director, Carol and James Herscot Center for Tuberous Sclerosis Complex. Professor of Neurology, Harvard Medical School. Orrin Devinsky, MD – Professor of Neurology, Neurosurgery, and Psychiatry at the NYU School of Medicine. Devinsky directs the NYU Comprehensive Epilepsy Center and is working on cannabis based clinical studies. Dustin Sulak, DO – founder of Integr8 Health, a medical practice treats over 18,000 patients with medical cannabis, Tested Labs, a cannabis analytic laboratory, and Healer.com, a medical cannabis patient education resource. Jeffrey Hergenrather, MD – President of the Society of Cannabis Clinicians and a cannabis consultation physician who practices in Northern California. Alexandros Makriyannis, PhD – Northeastern University Center for Drug Discovery. Staci Gruber PhD – Director, Cognitive and Clinical Neuroimaging Core and Director, Marijuana Investigations for Neuroscientific Discovery at McLean Hospital. Associate Professor of Psychiatry at Harvard Medical School. Sara Jane Ward, PhD – Assistant Professor, Center for Substance Abuse Research Department of Pharmacology, Lewis Katz School of Medicine at Temple University. Nolan Kane, PhD – Assistant Professor of Ecology and Evolutionary Biology at University of Boulder Colorado. Sean McAllister, PhD – Pharmacologist transforming cancer research to enable more precise therapies and fully personalized cancer care. … and many more! This year’s conference will include an option for health care professionals to earn continuing medical education credits (CMEs) in association with TheAnswerPage.com. Medical practitioners that choose this registration option will also be able to choose a non-profit organization to receive a donation through the Courtagen Gives Back Program. Early-bird discounts are available until February 28th. For additional details or to register for CannMed 2017, visit http://www.cannmedevents.com/ To learn more, visit Facebook, Twitter, and Instagram. Follow on social media with hashtags #CannMed #CannMed2017 Note to editors: Passes are available for accredited media upon request. About Medicinal Genomics Corporation Medicinal Genomics Corporation applies state-of-the-art life science technology to Cannabis plant genetics. Our products help growers, dispensaries, and safety testing laboratories characterize and understand the quality of medicinal cannabis. Medicinal Genomics utilizes a highly sophisticated Next Generation Sequencing laboratory, bioinformatics system, and DNA based technologies to deliver unmatched technical solutions to decipher the genetic code and quality level of medicinal Cannabis. Medicinal Genomics is a wholly owned subsidiary of Courtagen Life Sciences, Inc. For more information, please visit  http://www.medicinalgenomics.com/ About Courtagen Life Sciences, Inc. Courtagen Life Sciences, Inc., located in Woburn, MA, is a CLIA/CAP certified molecular information company focused on the diagnosis of a range of neurological disorders. Courtagen operates a highly sophisticated Next Generation DNA Sequencing, bioinformatics, and clinical interpretation business. Courtagen’s work helps physicians elucidate the linkages between the genotypes and phenotypes of various neurological diseases. For more information, please visit  http://www.courtagen.com/ Contacts

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Courtagen Life Sciences

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Courtagen Life Sciences is included in 3 Expert Collections, including Medical Devices.

M

Medical Devices

7,884 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

D

Digital Health

11,292 items

Technologies, platforms, and systems that engage consumers for lifestyle, wellness, or health-related purposes; capture, store, or transmit health data; and/or support life science and clinical operations. (DiME, DTA, HealthXL, & NODE.Health)

Courtagen Life Sciences Patents

Courtagen Life Sciences has filed 8 patents.

The 3 most popular patent topics include:

  • Biotechnology
  • DNA
  • Genetics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

11/22/2016

7/23/2019

Molecular biology, DNA, Biotechnology, Genetics, Polymerase chain reaction

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

11/22/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/23/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, DNA, Biotechnology, Genetics, Polymerase chain reaction

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.